Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Ribometrix
3121
Ribometrix
Technology
Biotechnology
Health Care
Medical
Pharmaceuticals
Ribometrix is a biotechnology company developing small molecule therapeutics that directly target RNA to treat human diseases.
Suggest edits
Raised
$37.5M
Follow us
Companies in the same industry
KannaLife Sciences
Aerie Pharmaceuticals
Prometheon Pharma
IDP Pharma
Galena Biopharma
Nevakar
Omeros Corporation
ApoGen Biotechnologies
PvP Biologics
Biscayne Pharmaceuticals, Inc.
Alexa global traffic share
Twitter followers
Overview
Funding
2
Add info
Latest funding
$30,000,000
Venture capital (Series A) - 2018
Amgen Ventures
Illumina Ventures
Pappas Capital
+1
$7,500,000
Seed fund - 2017
MP Healthcare Venture Management
Hatteras Venture Partners
AbbVie Ventures
+3
Team Size
1–10
Employees
I work here
Location
United States
Headquarters
Explore United States
$30,000,000
Venture capital (Series A)
PE HUB
Ribometrix scores $30 mln Series A
FinSMEs
,
Xconomy
Ribometrix Raises $30M in Series A Funding
$7,500,000
Seed fund
PE HUB
Biotech company Ribometrix snags $7.5 mln seed
